Acumen Pharmaceuticals Inc Sales to Fixed Assets Ratio 3 year CAGR is NA for the year ending December 31, 2023. Sales to fixed assets ratio measures the revenue generated by a company relative to its fixed assets, such as property, plant, and equipment. It is calculated by dividing the revenue by the net value of fixed assets. This ratio provides insights into the efficiency of the company's fixed assets in generating sales revenue. A higher sales to fixed assets ratio suggests better sales generation from fixed assets and efficient utilization of physical infrastructure. CAGR, or the Compound Annual Growth Rate, quantifies the mean annual growth rate of an investment or financial metric over a specified time span, considering the influence of compounding. It is instrumental in determining the true annualized return on an investment.